Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 6,894 Shares

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 6,894 shares of Omada Health stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $17.42, for a total value of $120,093.48. Following the sale, the chief accounting officer owned 9,191 shares in the company, valued at $160,107.22. This trade represents a 42.86% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Omada Health Stock Performance

OMDA opened at $17.11 on Wednesday. The business’s 50-day simple moving average is $15.54 and its 200-day simple moving average is $14.80. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92. The stock has a market capitalization of $1.02 billion and a P/E ratio of -63.37.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million for the quarter. On average, equities research analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Omada Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE increased its position in Omada Health by 51.5% during the 1st quarter. Bank of America Corp DE now owns 161,099 shares of the company’s stock worth $2,025,000 after purchasing an additional 54,792 shares during the period. Stoic Point Capital Management LLC acquired a new position in Omada Health during the 1st quarter worth approximately $1,830,000. Quantinno Capital Management LP increased its position in Omada Health by 464.1% during the 1st quarter. Quantinno Capital Management LP now owns 58,723 shares of the company’s stock worth $738,000 after purchasing an additional 48,313 shares during the period. Entropy Technologies LP acquired a new position in Omada Health during the 1st quarter worth approximately $194,000. Finally, Renaissance Technologies LLC increased its position in Omada Health by 173.9% during the 1st quarter. Renaissance Technologies LLC now owns 391,069 shares of the company’s stock worth $4,916,000 after purchasing an additional 248,269 shares during the period.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on OMDA. Needham & Company LLC restated a “buy” rating and issued a $28.00 price target on shares of Omada Health in a research report on Friday, May 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Omada Health in a research report on Thursday, June 4th. Wall Street Zen cut Omada Health from a “buy” rating to a “hold” rating in a research report on Saturday, May 30th. Morgan Stanley dropped their price target on Omada Health from $32.00 to $30.00 and set an “overweight” rating on the stock in a research report on Friday, March 6th. Finally, Citizens Jmp boosted their price target on Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.